Jennifer B. Damico
SVP & Controller, Pfizer.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 5, 2026Sold 3,278 shares at $25.40 of Pfizer2
- Jun 9, 2026Sold 2,000 shares at $25.70 of Pfizer3
- Mar 4, 2026Shares withheld for tax 826 shares at $26.62 of Pfizer4
- Mar 3, 2026Granted 5,408 shares of Pfizer4
- Mar 3, 2026Granted 16,311 shares of Pfizer4
- Feb 27, 2026Shares withheld for tax 655 shares at $27.65 of Pfizer5
- Feb 25, 2026Shares withheld for tax 16,687 shares at $26.92 of Pfizer6
- Feb 25, 2026Shares withheld for tax 361 shares at $27.09 of Pfizer6
- Feb 25, 2026Exercised options 17,558 shares at $33.82 of Pfizer6
- Feb 23, 2026Shares withheld for tax 419 shares at $27.06 of Pfizer7
- Mar 4, 2025Sold 2,500 shares at $25.93 of Pfizer8
- Mar 4, 2025Granted 5,583 shares of Pfizer8
- Feb 27, 2025Shares withheld for tax 20,994 shares at $26.06 of Pfizer9
- Feb 27, 2025Shares withheld for tax 553 shares at $26.10 of Pfizer9
- Feb 27, 2025Shares withheld for tax 749 shares at $26.10 of Pfizer8
- Feb 27, 2025Exercised options 22,416 shares at $31.31 of Pfizer9
- Feb 24, 2025Shares withheld for tax 377 shares at $26.65 of Pfizer10
- Feb 23, 2025Shares withheld for tax 390 shares at $26.30 of Pfizer11
- Feb 22, 2025Shares withheld for tax 7,798 shares at $26.08 of Pfizer11
- Feb 22, 2025Shares withheld for tax 390 shares at $26.30 of Pfizer11
- Feb 22, 2025Exercised options 8,741 shares at $30.17 of Pfizer11
- Aug 13, 2024Sold 5,154 shares at $28.66 of Pfizer12
- Feb 27, 2024Granted 5,113 shares of Pfizer13
- Feb 25, 2024Shares withheld for tax 1,386 shares at $27.76 of Pfizer14
- Feb 24, 2024Shares withheld for tax 354 shares at $27.76 of Pfizer14
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | PFE | Sale | $83.3K | +14.1% | −13.8% | |
| Jun 9, 2026 | PFE | Sale | $51.4K | +14.6% | −9.8% | |
| Mar 4, 2025 | PFE | Sale | $64.8K | +14.3% | +19.5% | +15.4% |
| Aug 13, 2024 | PFE | Sale | $147.7K | +2.0% | +40.3% | +31.8% |
| Mar 15, 2023 | PFE | Sale | $396.7K | −26.9% | +125.2% | +62.4% |
| Jun 7, 2022 | PFE | Sale | $227.6K | −45.4% | +131.1% | +30.5% |
| May 16, 2022 | PFE | Sale | $202.0K | −41.9% | +134.8% | +29.5% |
| Aug 13, 2021 | PFE | Sale | $80.2K | −39.3% | +112.4% | −6.4% |
| Jul 30, 2021 | PFE | Sale | $107.2K | −31.2% | +107.2% | −24.5% |
| May 5, 2021 | PFE | Sale | $102.0K | −26.3% | +112.0% | −21.7% |
| Jun 5, 2020 | PFE | Sale | $78.8K | −13.8% | +155.5% | +18.0% |
| Apr 29, 2020 | PFE | Sale | $83.6K | −18.6% | +181.8% | +36.5% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPfizer, SVP & Controller
- 2
- 3SEC EDGARForm 4 filed Jun 10, 2026
- 4SEC EDGARForm 4 filed Mar 5, 2026
- 5SEC EDGARForm 4 filed Mar 3, 2026
- 6SEC EDGARForm 4 filed Feb 27, 2026
- 7SEC EDGARForm 4 filed Feb 24, 2026
- 8SEC EDGARForm 4 filed Mar 6, 2025
- 9SEC EDGARForm 4 filed Mar 3, 2025
- 10SEC EDGARForm 4 filed Mar 3, 2025
- 11SEC EDGARForm 4 filed Feb 25, 2025
- 12SEC EDGARForm 4 filed Aug 14, 2024
- 13SEC EDGARForm 4 filed Feb 28, 2024
- 14SEC EDGARForm 4 filed Feb 27, 2024